Literature DB >> 21255624

Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus.

Zhijun Jie1, Darrell L Dinwiddie, Albert P Senft, Kevin S Harrod.   

Abstract

BACKGROUND/AIMS: Dendritic cells (DCs) act as a portal for virus invasion as well as potent antigen-presenting cells (APCs) involved in the antiviral host response. Interferons (IFNs) are produced in response to bacterial and viral infection and activate innate immune responses to efficiently counteract and remove pathogenic invaders. Respiratory syncytial virus (RSV) could inhibit IFN-mediated signaling pathway in epithelial cells; however, the effects of RSV on IFN signaling in the dendritic cells (DCs) are still unknown.
METHODS: Mouse bone marrow derived DCs (BMDCs) were mock or infected with RSV at different multiplicity of infection (MOI) for 24h, and then treated with different cytokines such as interferon-β (IFN-β), IFN-γ or interleukin-10 (IL-10). The mRNA expression of RSV nonstructural protein-1 (NS-1) and NS-2 was detected by RT-PCR. The expression of Janus family kinase-signal transducer and activator of transcription (JAK/STAT) signaling proteins was assessed by immunoblotting assays. The nuclear localization of specific signaling proteins was determined by immunofluorescence assay.
RESULTS: Increasing amounts of NS-1 or NS-2 mRNA expression in BMDCs were observed with infected RSV at increasing MOI, suggesting BMDCs were permissive for viral gene expression. Further examination of the IFN-β signaling cascade showed RSV infection increased the total cellular levels of STAT1 and STAT2 in BMDCs, but impaired the IFN-β-dependent phosphorylation and nuclear localization of STAT1 and STAT2. The inhibitory effects of RSV on STAT1 and STAT2 phosphorylation and translocation were abolished by UV inactivation. In contrast, RSV did not inhibit the IFN-γ-stimulated STAT1 phosphorylation and nuclear localization. IL-10-stimulated STAT3 phosphorylation was also unaffected by RSV.
CONCLUSIONS: As well as RSV inhibiting STAT protein levels through degradation mechanisms in epithelial cells, these findings demonstrate that RSV also can specifically inhibit the type I interferon response in BMDCs through regulation of STAT1 and STAT2 phosphorylation and nuclear translocation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255624      PMCID: PMC3726278          DOI: 10.1016/j.virusres.2011.01.007

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  35 in total

1.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.

Authors:  D S Finbloom; K D Winestock
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

3.  Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness.

Authors:  Mindy S Lo; Robert M Brazas; Michael J Holtzman
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.

Authors:  M Cella; D Jarrossay; F Facchetti; O Alebardi; H Nakajima; A Lanzavecchia; M Colonna
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

5.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.

Authors:  Murali Ramaswamy; Lei Shi; Martha M Monick; Gary W Hunninghake; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2004-01-12       Impact factor: 6.914

7.  The structure of the human interferon alpha/beta receptor gene.

Authors:  G Lutfalla; K Gardiner; D Proudhon; E Vielh; G Uzé
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

Review 8.  Virus infection of dendritic cells: portal for host invasion and host defense.

Authors:  Charles R Rinaldo; Paolo Piazza
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

9.  Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection.

Authors:  Marc Beyer; Holger Bartz; Katharina Hörner; Sandra Doths; Cordula Koerner-Rettberg; Jürgen Schwarze
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  11 in total

1.  Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo.

Authors:  M Del Rocío Baños-Lara; Arpita Ghosh; Antonieta Guerrero-Plata
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

2.  CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.

Authors:  Roberto Alfonso; Ariel Rodriguez; Paloma Rodriguez; Thomas Lutz; Amelia Nieto
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 3.  Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Authors:  Jop Jans; Marloes Vissers; Jacco G M Heldens; Marien I de Jonge; Ofer Levy; Gerben Ferwerda
Journal:  Rev Med Virol       Date:  2013-11-14       Impact factor: 6.989

4.  RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo.

Authors:  Catherine Ptaschinski; Sumanta Mukherjee; Martin L Moore; Mareike Albert; Kristian Helin; Steven L Kunkel; Nicholas W Lukacs
Journal:  PLoS Pathog       Date:  2015-06-17       Impact factor: 6.823

Review 5.  Recent advances in understanding viral evasion of type I interferon.

Authors:  Kathryne E Taylor; Karen L Mossman
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

6.  Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.

Authors:  Marcel A Schijf; Michael V Lukens; Debby Kruijsen; Nathalie O P van Uden; Johan Garssen; Frank E J Coenjaerts; Belinda Van't Land; Grada M van Bleek
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

7.  Respiratory Syncytial Virus Persistence in Murine Macrophages Impairs IFN-β Response but Not Synthesis.

Authors:  Evelyn Rivera-Toledo; Laura Torres-González; Beatriz Gómez
Journal:  Viruses       Date:  2015-10-16       Impact factor: 5.048

Review 8.  Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.

Authors:  Stephen B Fleming
Journal:  Vaccines (Basel)       Date:  2016-06-29

Review 9.  Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.

Authors:  Gisela Canedo-Marroquín; Orlando Acevedo-Acevedo; Emma Rey-Jurado; Juan M Saavedra; Margarita K Lay; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2017-08-16       Impact factor: 5.293

Review 10.  Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells.

Authors:  Eduardo I Tognarelli; Susan M Bueno; Pablo A González
Journal:  Front Immunol       Date:  2019-04-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.